Preclinical Comparison of the Blood-brain barrier Permeability of Osimertinib with Other EGFR TKIs. Colclough N, Chen K, Johnstrom P, Strittmatter N, et al. Clin Cancer Res 2021;27:189-201.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Colclough N, Chen K, Johnstrom P, Strittmatter N, et al. Preclinical Comparison of the Blood-brain barrier Permeability of Osimertinib with Other EGFR TKIs. Clin Cancer Res 2021;27:189-201.
PMID: 33028591